These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. Wong FL; Boice JD; Abramson DH; Tarone RE; Kleinerman RA; Stovall M; Goldman MB; Seddon JM; Tarbell N; Fraumeni JF; Li FP JAMA; 1997 Oct; 278(15):1262-7. PubMed ID: 9333268 [TBL] [Abstract][Full Text] [Related]
37. The role of photocoagulation in the management of retinoblastoma. Shields JA; Shields CL; Parsons H; Giblin ME Arch Ophthalmol; 1990 Feb; 108(2):205-8. PubMed ID: 2302102 [TBL] [Abstract][Full Text] [Related]
39. Suppression of bony growth of the orbit after radiotherapy for retinoblastoma. Egawa S; Tsukiyama I; Akine Y; Kajiura Y; Ogino T Radiat Med; 1987; 5(6):207-11. PubMed ID: 3452852 [TBL] [Abstract][Full Text] [Related]
40. Risk of radiation retinopathy in patients with orbital and ocular lymphoma. Kaushik M; Pulido JS; Schild SE; Stafford S Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1145-50. PubMed ID: 22592046 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]